ASGPR1 antibody [N1C3]
GTX122674
ApplicationsImmunoFluorescence, Western Blot, ImmunoCytoChemistry
Product group Antibodies
TargetASGR1
Overview
- SupplierGeneTex
- Product NameASGPR1 antibody [N1C3]
- Delivery Days Customer9
- Application Supplier NoteWB: 1:500-1:3000. ICC/IF: 1:100-1:1000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsImmunoFluorescence, Western Blot, ImmunoCytoChemistry
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration0.3 mg/ml
- ConjugateUnconjugated
- Gene ID432
- Target nameASGR1
- Target descriptionasialoglycoprotein receptor 1
- Target synonymsASGPR, ASGPR1, CLEC4H1, HL-1, asialoglycoprotein receptor 1, C-type lectin domain family 4 member H1, hepatic lectin H1
- HostRabbit
- IsotypeIgG
- Protein IDP07306
- Protein NameAsialoglycoprotein receptor 1
- Scientific DescriptionPartially deglycosylated plasma glycoproteins and immunoglobulin IgA2 allotypes are efficiently and specifically removed from circulation by a receptor-mediated process. The asialoglycoprotein receptor binds to desialylated (galactosyl-terminal) glycoproteins. It transports these glycoproteins via a series of membrane vesicles and tubules to an acidic-sorting organelle where the receptor and ligand dissociate. Then the receptor is recycled back to the cell surface and the ligand is transported to the lysosomes for degradation. [provided by RefSeq]
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- Povero D, Tameda M, Eguchi A, et al. Protein and miRNA profile of circulating extracellular vesicles in patients with primary sclerosing cholangitis. Sci Rep. 2022,12(1):3027. doi: 10.1038/s41598-022-06809-0Read this paper
- Kobayashi Y, Eguchi A, Tamai Y, et al. Protein Composition of Circulating Extracellular Vesicles Immediately Changed by Particular Short Time of High-Intensity Interval Training Exercise. Front Physiol. 2021,12:693007. doi: 10.3389/fphys.2021.693007Read this paper
- Povero D, Eguchi A, Li H, et al. Circulating extracellular vesicles with specific proteome and liver microRNAs are potential biomarkers for liver injury in experimental fatty liver disease. PLoS One. 2014,9(12):e113651. doi: 10.1371/journal.pone.0113651Read this paper
- Yeh TH, Wu FL, Shen LJ. Intracellular delivery of cytochrome c by galactosylated albumin to hepatocarcinoma cells. J Drug Target. 2014,22(6):528-35. doi: 10.3109/1061186X.2014.905947Read this paper
- Chen YH, Chou HC, Lin ST, et al. Effect of high glucose on secreted proteome in cultured retinal pigmented epithelium cells: its possible relevance to clinical diabetic retinopathy. J Proteomics. 2012,77:111-28. doi: 10.1016/j.jprot.2012.07.014Read this paper



